3Osta WA, Chen Y, Mikhitarian K, et al.EpCAM is overexpressed in breast cancerand is a potential tai^et for breast cancergene therapy [ J]. Cancer Res,2004,64(16):5818-5824.
4Su Z, Emdad L, Sauane M, et al. Uniqueaspects of MDA-7/IL-24 antitumor bystander activity : establishing a role forse-cretion of MDA-7/IL-24 protein by normolcell[J]. Oncogene,2005,24(51) :7552-7566.
5Teglund S, Toftgfird R. Hedgehog beyondmedulloblastoma and basal cell carcinoma[J]. Biochim Biophys Acta,2010,1805(2):181-208.
6Heretsch P, Tzagkaroulaki L, Giannis A.Modulators of the hedgehog signaling path-way [J ].. Bioorg Med Chem, 2010, 18(18):6613-6624.
7Kang NH, Hwang KA, Yi BR, et al. Hu-man amnioticfluid-derived stem cells ex-pressing cytosine deaminase and thymidinekinase inhibits the growth of breast cancercells in cellular and xenograft mouse mod-els[ J]. Cancer Gene Ther,2012,19(6):412-419.
8Pastorakova A, Hlubinova K, Bodo J, etal. Tumor targeted gene therapy with plas-mid expressing human tumor necrosis fac-tor alpha in vitro and in vivo[ J]. Neoplas-ma,2005,52(4) :344-351.
9Bender LM,Nahta R. Her2 cross talk andtherapeutic resistance in breast cancer[J]. Front Biosci’2008,13:3906-3912.
10Marukawa Y ’ Nakamoto Y,Kakinoki K,etal. Membranebound form of monocyte che-moattractant protein-1 enhances antitumoreffects of suicide gene therapy in a modelof hepatocellular carcinoma [ J ]. CancerGene Ther,2012,19(5) :312-319.
3Naidu R,Wahab NA,Yadav M,et al.Protection expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.Int J Mol Med,2002,9:189-196.
4Ciesielski D,Dziewulska BA,Ioltowska A,et al.p53 expression in breast cancer related to prognostic factors.Neoplasma,1995,42:235-237.
5Arteaga CL,Holt JT.Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice.Cancer Rea,1996,56:1098-1103.
6Lee EJ,Jakacka M,Duan WR,et al.Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice.Mol Med,2001,7:773-782.
7Obermiller PS,Tait DL,Holt JT.Gene therapy for carcinoma of the breast::Therapeutic genetic corretion strategies.Breast Cancer Res,2000,2:28-31.
8Xu HJ,Zhou Y,Seigne J,et al.Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.Cancer Res,1996,56:2245-2249.
9Li Z,Shanmugan N,Katayose D,et al.Enzyme/prudrug gene therapy approach for breast cancer using a recombinant adenovirus expressing escherichia coli cytosine deaminase.Cancer Gene Ther,1997,4:113-117.
10Pandha HS,Martin LA,Rigg A,et al.Genetic prodrug activation therapy for breast cancer:A phase clinical trial of erbB-2-directed suicide gene expression.J Clin Oncol,1999,17:2180-2189.
